New Target Identified for Scleroderma Therapy
Monday, June 14, 2010 - 16:00
in Health & Medicine
(PhysOrg.com) -- Investigators at Northwestern University Feinberg School of Medicine have identified the molecule Egr-1 (early growth response factor 1) as a new therapy target for scleroderma, an autoimmune disease for which there currently is no cure.